Philip Bonomi to Breast Neoplasms
This is a "connection" page, showing publications Philip Bonomi has written about Breast Neoplasms.
Connection Strength
0.345
-
Quantitative estrogen and progesterone receptor levels related to progression-free interval in advanced breast cancer patients treated with megestrol acetate or tamoxifen. Semin Oncol. 1988 Apr; 15(2 Suppl 1):26-33.
Score: 0.062
-
Primary hormonal therapy of advanced breast cancer with megestrol acetate: predictive value of estrogen receptor and progesterone receptor levels. Semin Oncol. 1985 Mar; 12(1 Suppl 1):48-54.
Score: 0.050
-
Metastatic breast cancer from an occult primary provisionally identified by steroid receptor content and two-dimensional protein electrophoresis: some problems associated with the use of the latter technique. Clin Physiol Biochem. 1985; 3(5):265-70.
Score: 0.049
-
Comparison of several model-based methods for analysing incomplete quality of life data in cancer clinical trials. Stat Med. 1998 Mar 15-Apr 15; 17(5-7):781-96.
Score: 0.031
-
Fadrozole HCL (CGS-16949A) versus megestrol acetate treatment of postmenopausal patients with metastatic breast carcinoma: results of two randomized double blind controlled multiinstitutional trials. Cancer. 1996 Jun 15; 77(12):2503-13.
Score: 0.027
-
Megestrol acetate as primary hormonal therapy for advanced breast cancer. Semin Oncol. 1988 Apr; 15(2 Suppl 1):34-7.
Score: 0.015
-
Sequential hormone therapy for advanced breast cancer. Semin Oncol. 1988 Apr; 15(2 Suppl 1):38-43.
Score: 0.015
-
Hormone receptor studies in axillary metastases from occult breast cancers. Cancer. 1987 Mar 15; 59(6):1170-2.
Score: 0.014
-
Megestrol acetate v tamoxifen in advanced breast cancer: correlation of hormone receptors and response. Semin Oncol. 1986 Dec; 13(4 Suppl 4):9-14.
Score: 0.014
-
Megestrol acetate: first-line therapy for advanced breast cancer. Semin Oncol. 1986 Dec; 13(4 Suppl 4):15-9.
Score: 0.014
-
Metastatic breast cancer: preliminary results with oral hormonal therapy. Semin Oncol. 1985 Dec; 12(4 Suppl 6):61-4.
Score: 0.013
-
Progesterone receptor level as a predictor of response to megestrol acetate in advanced breast cancer: a retrospective study. Cancer Treat Rep. 1983 Jul-Aug; 67(7-8):717-20.
Score: 0.011
-
Response to megestrol in male breast carcinoma. Arch Intern Med. 1981 May; 141(6):809-10.
Score: 0.010
-
Comparison of dextran-coated charcoal and sucrose density gradient analyses of estrogen and progesterone receptors in human breast cancer. Cancer Res. 1980 Nov; 40(11):4127-32.
Score: 0.009
-
Stabilization of human breast cancer progesterone (5020) receptor by sodium molybdate. Clin Chim Acta. 1980 May 09; 103(3):367-73.
Score: 0.009